The global biopharmaceutical company has ordered the APAS Independence automated microbiological monitoring platform under a five-year lease agreement, which will undergo evaluation and validation
CSL is an Australia-based biotechnology company that develops and commercializes novel therapeutics and vaccines for the treatment of various diseases.